Maravai LifeSciences Holdings, Inc. Class A Share Price

Maravai LifeSciences Holdings, Inc. Class A Share Price

NASDAQ: MRVI | Small Cap
$8.43
-$0.08 (-0.88%) Last updated on 29 Oct, 2026 | 20:39 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Maravai LifeSciences Holdings, Inc. Class A Stock Performance

Open
$8.46
Prev. Close
$8.51
Circuit Range
N/A
Day Range
$8.36 - $8.56
Year Range
$2.59 - $9.40
Volume
23,381
Average Traded
$8.45

Maravai LifeSciences Holdings, Inc. Class A Share Price Today

As of 29 October 2026, Maravai LifeSciences Holdings, Inc. Class A's share price is $8.43. The stock opened at $8.46, compared to its previous close of $8.51. During today's trading session, Maravai LifeSciences Holdings, Inc. Class A's share price traded between $8.36 and $8.56, with an average price of $8.46. Over the past 52 weeks, the stock has recorded a high of $9.40 and a low of $2.59. In terms of performance, Maravai LifeSciences Holdings, Inc. Class A's share price has risen by 129.39% over the last six months and is up 169.33% on a year-on-year basis.

Maravai LifeSciences Holdings, Inc. Class A Share Price Chart

Line chart of the Maravai LifeSciences Holdings, Inc. Class A price trend over the selected period. The price fell overall, ranging from 8.36 to 8.58, ending at 8.43.
$8.36$8.56
L
Show Current Price
H

Maravai LifeSciences Holdings, Inc. Class A Stock Fundamentals & Key Indicators

Market Cap
$1.22B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.52
Revenue (TTM)
$185.74B
Return On Equity (TTM)
-37.82%
Profit Margin
-70.40%
Debt to Equity
0.86
Quarterly Earnings Growth YoY
51.41%

Maravai LifeSciences Holdings, Inc. Class A Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$41.63$49.87$65.84$51.44
Net Profit-$25.56-$35.68-$3.73-$12.42
Net Profit Margin-61.40%-71.55%-5.67%-24.14%
Income ChangeN/A-39.59%89.55%-232.98%

Maravai LifeSciences Holdings, Inc. Class A Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$883.00$288.95$259.19$185.74
Net Profit$220.21-$119.03-$144.85-$130.77
Net Profit Margin24.94%-41.19%-55.89%-70.40%
Income ChangeN/A-154.05%-21.69%9.72%

About Maravai LifeSciences Holdings, Inc. Class A

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

Maravai LifeSciences Holdings, Inc. Class A Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$7.67
$8.36
+9.00%
Sep 2026
$7.59
$7.67
-8.25%
Aug 2026
$6.58
$8.36
+27.25%
Jul 2026
$6.19
$6.57
+5.37%
Jun 2026
$4.75
$6.24
+29.63%
May 2026
$3.68
$4.81
+30.88%
Apr 2026
$2.87
$3.67
+29.86%
Mar 2026
$3.52
$2.83
-20.73%
Feb 2026
$3.42
$3.57
+5.93%
Jan 2026
$3.27
$3.37
+3.37%
Dec 2025
$3.56
$3.26
-9.70%
Nov 2025
$3.16
$3.61
+15.34%

MRVI Share Price FAQs